| Mitchell K Pratte, DO | |
|
1975 N State St, Orem, UT 84057-2028 | |
| (801) 714-5500 | |
| Not Available |
| Full Name | Mitchell K Pratte |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 1975 N State St, Orem, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396782207 | NPI | - | NPPES |
| D2631 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 364166 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Orem Community Hospital | Orem, UT | Hospital |
| Utah Valley Hospital | Provo, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
| Utah Valley Emergency Physicians Inc | 2860390879 | 34 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Acyclovir Ointment USP, 5%.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today announced that a cross of 1,480,000 common shares has been effected through Canaccord Capital Inc. at a sales price of $0.05 per common share.
A new study co-authored by the University of Kentucky's Dr. John O'Brien found that applying vaginal progesterone to women who are at a high risk of preterm birth significantly decreased the odds of a premature delivery.
Researchers from the Cancer Science Institute of Singapore at the National University of Singapore have discovered that the BCL6 protein could potentially be used as a marker to predict clinical outcomes of patients suffering from Glioblastoma Multiforme, the most malignant cancer of the brain.
A team of researchers from Case Western Reserve University School of Medicine has helped uncover the elusive structure of a cancer cell receptor protein that can be leveraged to fight disease progression.
› Verified 8 days ago
| Entity Name | Utah Valley Emergency Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649204553 PECOS PAC ID: 2860390879 Enrollment ID: O20040727000274 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Acyclovir Ointment USP, 5%.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today announced that a cross of 1,480,000 common shares has been effected through Canaccord Capital Inc. at a sales price of $0.05 per common share.
A new study co-authored by the University of Kentucky's Dr. John O'Brien found that applying vaginal progesterone to women who are at a high risk of preterm birth significantly decreased the odds of a premature delivery.
Researchers from the Cancer Science Institute of Singapore at the National University of Singapore have discovered that the BCL6 protein could potentially be used as a marker to predict clinical outcomes of patients suffering from Glioblastoma Multiforme, the most malignant cancer of the brain.
A team of researchers from Case Western Reserve University School of Medicine has helped uncover the elusive structure of a cancer cell receptor protein that can be leveraged to fight disease progression.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Acyclovir Ointment USP, 5%.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today announced that a cross of 1,480,000 common shares has been effected through Canaccord Capital Inc. at a sales price of $0.05 per common share.
A new study co-authored by the University of Kentucky's Dr. John O'Brien found that applying vaginal progesterone to women who are at a high risk of preterm birth significantly decreased the odds of a premature delivery.
Researchers from the Cancer Science Institute of Singapore at the National University of Singapore have discovered that the BCL6 protein could potentially be used as a marker to predict clinical outcomes of patients suffering from Glioblastoma Multiforme, the most malignant cancer of the brain.
A team of researchers from Case Western Reserve University School of Medicine has helped uncover the elusive structure of a cancer cell receptor protein that can be leveraged to fight disease progression.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mitchell K Pratte, DO Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 714-5500 | Mitchell K Pratte, DO 1975 N State St, Orem, UT 84057-2028 Ph: (801) 714-5500 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Acyclovir Ointment USP, 5%.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today announced that a cross of 1,480,000 common shares has been effected through Canaccord Capital Inc. at a sales price of $0.05 per common share.
A new study co-authored by the University of Kentucky's Dr. John O'Brien found that applying vaginal progesterone to women who are at a high risk of preterm birth significantly decreased the odds of a premature delivery.
Researchers from the Cancer Science Institute of Singapore at the National University of Singapore have discovered that the BCL6 protein could potentially be used as a marker to predict clinical outcomes of patients suffering from Glioblastoma Multiforme, the most malignant cancer of the brain.
A team of researchers from Case Western Reserve University School of Medicine has helped uncover the elusive structure of a cancer cell receptor protein that can be leveraged to fight disease progression.
› Verified 8 days ago
Dr. Jeffrey Madsen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 W 800 N, Orem, UT 84057 Phone: 801-714-6570 | |
Ronald P Barlow, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 W 800 N, Er Department, Orem, UT 84057 Phone: 801-714-6570 | |
Vernon L Christenson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1975 N State St, Orem, UT 84057 Phone: 801-714-5000 | |
Justin D Pearson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 W 800 N, Orem, UT 84057 Phone: 801-714-6570 | |
Dr. Jacob Lawrence Camp, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 331 N 400 W, Orem, UT 84057 Phone: 801-224-4080 | |
Micah Jeremy Smith, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 750 W 800 N, Orem, UT 84057 Phone: 801-714-6570 Fax: 801-714-6588 |